QuidelOrtho Corp. Stock Plummets to New 52-Week Low of $17.08

QuidelOrtho Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 17.08 on March 13, 2026. This marks a significant decline, with the stock's performance over the past year showing a decrease of 58.41%, contrasting sharply with the S&P 500's gain of 20.12% during the same period. The company's market capitalization stands at USD 1,530 million, reflecting its small-cap status. QuidelOrtho has faced ongoing financial difficulties, reporting negative results for the last 12 consecutive quarters. Key financial metrics reveal a debt-equity ratio of 1.31, indicating a higher reliance on debt, while the return on equity is at -7.95%. The stock's price-to-book ratio is notably low at 0.80, suggesting that it may be undervalued relative to its assets. With a dividend yield of 0.00%, QuidelOrtho has not provided returns to shareholders through dividends. The stock's performance has consistently underperformed against the S&P 500 over the last three years, highlighting ongoing challenges within the company.